Please try another search
Sensorion SA, a biotechnology company, develops drug candidates for the treatment of inner ear disorders in France. Its pipeline includes various products in the development stage for restoring, treating, and preventing inner ear related disorders. The company’s product portfolio includes SENS-401 SSNHL, which has completed Phase 2 clinical trial for the treatment of Sudden Sensorineural Hearing Loss; SENS-401 CIO that is in Phase 2 clinical trial for the treatment of Cisplatin-Induced Ototoxicity; and SENS-401 Cochlear, which is in Phase 2 clinical trial for the treatment of hearing preservation after cochlear implantation. It is also developing OTOF-GT (SENS-501), a gene therapy development program that has completed Phase 1 clinical trial to restore hearing in people living with Otoferlin deficiency; and GJB2-GT, a gene therapy development program, which is in pre-clinical trial to restore hearing in people living with hearing loss due to mutations in the GJB2 gene. The company was incorporated in 2009 and is headquartered in Montpellier, France.
Name | Age | Since | Title |
---|---|---|---|
Nawal Ouzren | 43 | 2017 | CEO & Director |
Christine Petit | - | 2018 | Chair of Scientific Advisory Board |
Eric Forquenot de La Fortelle | - | - | Independent Director |
Khalil Barrage | 58 | 2019 | Interim Chair |
Paul Avan | - | 2020 | Member of Scientific Advisory Board |
Robert J. Dow | 72 | 2020 | Member of Scientific Advisory Board |
Hernán López-Schier | - | 2020 | Member of Scientific Advisory Board |
Alain Fischer | - | 2020 | Member of Scientific Advisory Board |
Diane Lazard | - | 2020 | Member of Scientific Advisory Board |
Aniz Girach | 56 | 2022 | Independent Director |
Natalie Brittenham Berner | 32 | 2023 | Director |
Cédric Moreau | - | 2019 | Director |
Julien Miara | 41 | 2019 | Director |
John P. Furey | 59 | 2019 | Independent Director |
Florian Reinaud | 51 | 2023 | Board Observer |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review